Summit Partners Public Asset Management »

Bridgebio Pharma shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $42M 807k 51.94
2025-06-30 $33M 758k 43.18
2025-03-31 $39M 1.1M 34.57

More positions owned by Summit Partners Public Asset Management

Spotify Technology S A SHS (SPOT)
Insmed Com Par $.01 Call Option (INSM)
Verona Pharma Sponsored Ads (VRNA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Ge Vernova (GEV)
Microsoft Corporation (MSFT)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A Put Option (SEI)
Mongodb Cl A Put Option (MDB)
Rubrik Cl A (RBRK)
Genedx Holdings Corp Com Cl A (WGS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
MKS Instruments Call Option (MKSI)
Astera Labs (ALAB)

View all positions for Summit Partners Public Asset Management

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma